Integration of proteomics and transcriptomics to construct a prognostic signature of renal clear cell carcinoma

被引:1
作者
Cheng, Guangyang [1 ]
Zhou, Zhaokai [1 ,2 ,3 ]
Li, Shiqi [1 ]
Ye, Zhuo [1 ]
Wang, Yan [1 ]
Wen, Jianguo [1 ,2 ,3 ]
Ren, Chuanchuan [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Henan Joint Int Pediat Urodynam Lab, Zhengzhou 450052, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Bladder Struct & Funct Reconstruct Henan Engn Lab, Zhengzhou 450052, Henan, Peoples R China
来源
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2024年 / 21卷 / 11期
基金
中国国家自然科学基金;
关键词
Proteomics; Transcriptomics; Renal clear cell carcinoma; Prognostic signature; tumor microenvironment; CANCER; P21; IDENTIFICATION; EFFICACY; RPS6KB1;
D O I
10.7150/ijms.99992
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Protein information is often replaced by RNA data in studies to understand cancer-related biological processes or molecular functions, and proteins of prognostic significance in Kidney clear cell carcinoma (KIRC) remain to be mined. Methods: The cancer genome atlas program (TCGA) data was utilized to screen for proteins that are prognostically significant in KIRC. Machine learning algorithms were employed to develop protein immunotherapeutic responses were analyzed in various protein risk subgroups. Ultimately, the validation of protein-coding genes was confirmed by utilizing an online database and implementing quantitative Results: The patients were divided into two risk categories based on prognostic proteins, and notable disparities in both overall survival (OS) and progression free interval (PFI) were observed between the two groups. The OS was more unfavorable in the high-risk group, and there was a noteworthy disparity in the level of immune infiltration observed between the two groups. In addition, the nomogram showed high accuracy in predicting survival in KIRC patients. Conclusion: In this research, we elucidated the core proteins associated with prognosis in terms of survival prediction, immunotherapeutic response, somatic mutation, and immune microenvironment. Additionally, we have developed a reliable prognostic model with excellent predictive capabilities.
引用
收藏
页码:2215 / 2232
页数:18
相关论文
共 50 条
[1]   miR-5191 functions as a tumor suppressor by targeting RPS6KB1 in colorectal cancer [J].
An, Hyun-Ju ;
Park, Misun ;
Kim, Joon ;
Han, Young-Hoon .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (04) :960-972
[2]   Diablo: A Double-Edged Sword in Cancer? [J].
Arbiser, Jack L. .
MOLECULAR THERAPY, 2018, 26 (03) :678-679
[3]   p70 Ribosomal protein S6 kinase (Rps6kb1): an update [J].
Bahrami-B, Farnaz ;
Ataie-Kachoie, Parvin ;
Pourgholami, Mohammad H. ;
Morris, David L. .
JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (12) :1019-1025
[4]   Treatment of renal cell carcinoma: Current status and future directions [J].
Barata, Pedro C. ;
Rini, Brian I. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) :507-524
[5]  
Blanco Angel I, 2011, Cancers (Basel), V3, P4010, DOI 10.3390/cancers3044010
[6]   miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer [J].
Cai, Chao ;
Chen, Qing-Biao ;
Han, Zhao-Dong ;
Zhang, Yan-Qiong ;
He, Hui-Chan ;
Chen, Jia-Hong ;
Chen, Yan-Ru ;
Yang, Sheng-Bang ;
Wu, Yong-Ding ;
Zeng, Yan-Ru ;
Qin, Guo-Qiang ;
Liang, Yu-Xiang ;
Dai, Qi-Shan ;
Jiang, Fu-Neng ;
Wu, Shu-lin ;
Zeng, Guo-Hua ;
Zhong, Wei-De ;
Wu, Chin-Lee .
CLINICAL CANCER RESEARCH, 2015, 21 (21) :4922-4934
[7]   Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma (vol 179, pg 964, 2019) [J].
Clark, David J. ;
Dhanasekaran, Saravana M. ;
Petralia, Francesca ;
Pan, Jianbo ;
Song, Xiaoyu ;
Hu, Yingwei ;
Leprevost, Felipe da Veiga ;
Reva, Boris ;
Lih, Tung-Shing M. ;
Chang, Hui-Yin ;
Ma, Weiping ;
Huang, Chen ;
Ricketts, Christopher J. ;
Chen, Lijun ;
Krek, Azra ;
Li, Yize ;
Rykunov, Dmitry ;
Li, Qing Kay ;
Chen, Lin S. ;
Ozbek, Umut ;
Vasaikar, Suhas ;
Wu, Yige ;
Yoo, Seungyeul ;
Chowdhury, Shrabanti ;
Wyczalkowski, Matthew A. ;
Ji, Jiayi ;
Schnaubelt, Michael ;
Kong, Andy ;
Sethuraman, Sunantha ;
Avtonomov, Dmitry M. ;
Ao, Minghui ;
Colaprico, Antonio ;
Cao, Song ;
Cho, Kyung-Cho ;
Kalayci, Selim ;
Ma, Shiyong ;
Liu, Wenke ;
Ruggles, Kelly ;
Calinawan, Anna ;
Gumus, Zeynep H. ;
Geiszler, Daniel ;
Kawaler, Emily ;
Teo, Guo Ci ;
Wen, Bo ;
Zhang, Yuping ;
Keegan, Sarah ;
Li, Kai ;
Chen, Feng ;
Edwards, Nathan ;
Pierorazio, Phillip M. .
CELL, 2020, 180 (01) :207-207
[8]  
Clark DJ, 2019, CANCER RES, V79, DOI [10.1158/1538-7445.AM2019-2458, 10.1016/j.cell.2019.10.007]
[9]   ERRFI1 induces apoptosis of hepatocellular carcinoma cells in response to tryptophan deficiency [J].
Cui, Mingqing ;
Liu, Dan ;
Xiong, Wujun ;
Wang, Yugang ;
Mi, Jun .
CELL DEATH DISCOVERY, 2021, 7 (01)
[10]   CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma [J].
Di, Jiehui ;
Wang, Hui ;
Zhao, Zhongjun ;
Zhao, Guang ;
Qin, Xiaobing ;
Han, Zhengxiang ;
Liu, Yong .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9